SHENYANG, China, April 29 3SBio Inc.(Nasdaq: SSRX), a leading China-based biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, today announced that it will release unaudited financial results forthe first quarter ended March 31, 2008 after the US market closes on Wednesday,May 14, 2008.
The earnings release will be available on the investor relations page ofits website at: http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .
Following the earnings announcement, 3SBio Inc. senior management willhost a conference call at 5:00 am (Pacific) / 8:00 am (Eastern) / 8:00 pm(Beijing/Hong Kong) on Thursday, May 15, 2008 to discuss its 2008 firstquarter financial results and recent business activity. The conference callmay be accessed by calling (US) +1 480 248 5081 / (UK) +44 (0) 20 8515 2301 /(HK) +852 3009 5027. A telephone replay will be available shortly after thecall until May 29, 2008 at (US) +1 303 590 3030/ (UK) +44 (0)20 7154 2833,Passcode: 3872203; and (HK) +852 2287 4304, Passcode: 030 110#.
A live webcast of the conference call and replay will be available on theinvestor relations page of 3SBio's website at:http://www.3sbio.com/en/News/ShowInfo_nnn5.aspx?ID=64 .
About 3SBio Inc.
3SBio Inc. is a leading, fully integrated biotechnology company focused onresearching, developing, manufacturing and marketing biopharmaceuticalproducts, primarily in China.
For more information, please visit 3SBio on the web at:http://www.3sbio.com .For more information, please contact: Investor Contact: Kevin Teo, CFO 3SBio Inc. Tel: +86-24-2581-1820 Investor Relations (US): Mahmoud Siddig Taylor Rafferty Tel: +1-212-889-4350 Investor Relations (HK): Ruby Yim Taylor Rafferty Tel: +852-3196-3712 Media Contact: Jason Marshall Taylor Rafferty Tel: +1-212-889-4350
SOURCE 3SBio Inc.